Article
Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
The American journal of gastroenterology - 1 Jun 2021
Gil-Gómez Antonio, Ampuero Javier, Rojas Ángela, Gallego-Durán Rocío, Muñoz-Hernández Rocío, Rico María C, Millán Raquel, García-Lozano Raúl, Francés Rubén, Soriano Germán, Romero-Gómez Manuel
Abstract excerpt
INTRODUCTION: We aimed to define the impact of the genetic background on overt hepatic encephalopathy (HE) in patients with liver cirrhosis by developing a combined clinical-genetic risk score. METHODS: Patients suffering from liver cirrhosis from the outpatient clinics of 4 hospitals (n = 600) were included and followed up for at least 5 years until HE bouts, liver transplant, or death. Patients were genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
